Clinical

Dataset Information

0

The research of Sanghuangporusbaumii tablets on immune regulation of colorectal cancer patients after chemotherapy


ABSTRACT: Interventions: Experimental group:OralSanghuangporusbaumii tablets (15g per person per day, 200ml of boiling water for 15min, filter out the supernatant, then 200ml of boiling water for 15min, filter out the supernatant, combine the two supernatants for oral use), continuous treatment for 2 weeks;Positive control group:The patient was treated with thymofaxine (1.6 mg subcutaneously twice a week) for 2 consecutive weeks. Primary outcome(s): Immunocompromised control ratio;Immune function index;Adverse reactions;Symptom score Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2725875 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2623383 | ecrin-mdr-crc
2012-03-17 | E-GEOD-36576 | biostudies-arrayexpress
| PRJNA565392 | ENA
2016-03-19 | GSE79394 | GEO
2016-01-05 | GSE76500 | GEO
2013-09-01 | E-GEOD-50519 | biostudies-arrayexpress
2007-08-24 | E-SMDB-4129 | biostudies-arrayexpress
2019-04-30 | GSE128896 | GEO
2007-09-19 | GSE5868 | GEO
2021-10-19 | GSE103818 | GEO